-
1
-
-
0035254218
-
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
-
Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
-
(2001)
J Clin Oncol
, vol.19
, pp. 666-675
-
-
Stein, J.P.1
Lieskovsky, G.2
Cote, R.3
-
2
-
-
0035097992
-
Cystectomy for bladder cancer: A contemporary series
-
Dalbagni G., Genega E., Hashibe M., et al. Cystectomy for bladder cancer: A contemporary series. J Urol 165 (2001) 1111-1116
-
(2001)
J Urol
, vol.165
, pp. 1111-1116
-
-
Dalbagni, G.1
Genega, E.2
Hashibe, M.3
-
3
-
-
0037441652
-
Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy
-
Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21 (2003) 690-696
-
(2003)
J Clin Oncol
, vol.21
, pp. 690-696
-
-
Madersbacher, S.1
Hochreiter, W.2
Burkhard, F.3
-
4
-
-
33745231164
-
Cystectomy for transitional cell carcinoma of the bladder: Results of a surgery only series in the neobladder era
-
Hautmann R.E., Gschwend J.E., de Petriconi R.C., et al. Cystectomy for transitional cell carcinoma of the bladder: Results of a surgery only series in the neobladder era. J Urol 176 (2006) 486-492
-
(2006)
J Urol
, vol.176
, pp. 486-492
-
-
Hautmann, R.E.1
Gschwend, J.E.2
de Petriconi, R.C.3
-
5
-
-
85014013850
-
Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial
-
International Collaboration of Trialists
-
International Collaboration of Trialists. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial. Lancet 354 (1999) 533-540
-
(1999)
Lancet
, vol.354
, pp. 533-540
-
-
-
6
-
-
0041429507
-
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
-
Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
-
(2003)
N Engl J Med
, vol.349
, pp. 859-866
-
-
Grossman, H.B.1
Natale, R.B.2
Tangen, C.M.3
-
7
-
-
0000278788
-
Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
-
UKCCCR Anal Cancer Trial Working Party
-
UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348 (1996) 1049-1054
-
(1996)
Lancet
, vol.348
, pp. 1049-1054
-
-
-
8
-
-
0025807080
-
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
-
Department of Veterans Affairs Laryngeal Cancer Study Group
-
Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324 (1991) 1685-1690
-
(1991)
N Engl J Med
, vol.324
, pp. 1685-1690
-
-
-
9
-
-
0029851252
-
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group
-
Coppin C.M., Gospodarowicz M.K., James K., et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14 (1996) 2901-2907
-
(1996)
J Clin Oncol
, vol.14
, pp. 2901-2907
-
-
Coppin, C.M.1
Gospodarowicz, M.K.2
James, K.3
-
10
-
-
0031763392
-
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03
-
Shipley W.U., Winter K.A., Kaufman D.S., et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16 (1998) 3576-3583
-
(1998)
J Clin Oncol
, vol.16
, pp. 3576-3583
-
-
Shipley, W.U.1
Winter, K.A.2
Kaufman, D.S.3
-
11
-
-
33644838678
-
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
-
Lin C.C., Hsu C.H., Huang C.Y., et al. Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity. Cancer 106 (2006) 1269-1275
-
(2006)
Cancer
, vol.106
, pp. 1269-1275
-
-
Lin, C.C.1
Hsu, C.H.2
Huang, C.Y.3
-
12
-
-
33845342862
-
Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma
-
Lin C.C., Hsu C.H., Huang C.Y., et al. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma. J Urol 177 (2007) 84-89
-
(2007)
J Urol
, vol.177
, pp. 84-89
-
-
Lin, C.C.1
Hsu, C.H.2
Huang, C.Y.3
-
13
-
-
33947254983
-
Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens
-
Lin C.C., Hsu C.H., Huang C.Y., et al. Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens. Urology 69 (2007) 479-484
-
(2007)
Urology
, vol.69
, pp. 479-484
-
-
Lin, C.C.1
Hsu, C.H.2
Huang, C.Y.3
-
14
-
-
0028969271
-
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
-
Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
-
(1995)
Int J Radiat Oncol Biol Phys
, vol.31
, pp. 1341-1346
-
-
Cox, J.D.1
Stetz, J.2
Pajak, T.F.3
-
15
-
-
0024536437
-
Optimal two-stage designs for phase II clinical trials
-
Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10 (1989) 1-10
-
(1989)
Control Clin Trials
, vol.10
, pp. 1-10
-
-
Simon, R.1
-
16
-
-
1542299243
-
Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder
-
Michaelson M.D., Shipley W.U., Heney N.M., et al. Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder. Br J Cancer 90 (2004) 578-581
-
(2004)
Br J Cancer
, vol.90
, pp. 578-581
-
-
Michaelson, M.D.1
Shipley, W.U.2
Heney, N.M.3
-
17
-
-
0141615695
-
RTOG 97-06: Initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy
-
Hagan M.P., Winter K.A., Kaufman D.S., et al. RTOG 97-06: Initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 665-672
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 665-672
-
-
Hagan, M.P.1
Winter, K.A.2
Kaufman, D.S.3
-
18
-
-
0027452436
-
Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study
-
Housset M., Maulard C., Chretien Y., et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study. J Clin Oncol 11 (1993) 2150-2157
-
(1993)
J Clin Oncol
, vol.11
, pp. 2150-2157
-
-
Housset, M.1
Maulard, C.2
Chretien, Y.3
-
19
-
-
0036290017
-
Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer
-
Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer. Urology 60 (2002) 62-67
-
(2002)
Urology
, vol.60
, pp. 62-67
-
-
Shipley, W.U.1
Kaufman, D.S.2
Zehr, E.3
-
20
-
-
0037099683
-
Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results
-
Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 20 (2002) 3061-3071
-
(2002)
J Clin Oncol
, vol.20
, pp. 3061-3071
-
-
Rodel, C.1
Grabenbauer, G.G.2
Kuhn, R.3
-
21
-
-
34447096867
-
Long-term outcome of radiation-based conservation therapy for invasive bladder cancer
-
Chung P.W., Bristow R.G., Milosevic M.F., et al. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol 25 (2007) 303-309
-
(2007)
Urol Oncol
, vol.25
, pp. 303-309
-
-
Chung, P.W.1
Bristow, R.G.2
Milosevic, M.F.3
-
22
-
-
0031868628
-
Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: A long-term follow-up of 276 consecutive patients
-
Wijkstrom H., Norming U., Lagerkvist M., et al. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: A long-term follow-up of 276 consecutive patients. Br J Urol 81 (1998) 686-691
-
(1998)
Br J Urol
, vol.81
, pp. 686-691
-
-
Wijkstrom, H.1
Norming, U.2
Lagerkvist, M.3
-
23
-
-
0343775631
-
Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: Possible predictors for response to radiochemotherapy and successful bladder preservation
-
Rodel C., Grabenbauer G.G., Rodel F., et al. Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: Possible predictors for response to radiochemotherapy and successful bladder preservation. Int J Radiat Oncol Biol Phys 46 (2000) 1213-1221
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.46
, pp. 1213-1221
-
-
Rodel, C.1
Grabenbauer, G.G.2
Rodel, F.3
-
24
-
-
21044446131
-
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group
-
Chakravarti A., Winter K., Wu C.L., et al. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 62 (2005) 309-317
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.62
, pp. 309-317
-
-
Chakravarti, A.1
Winter, K.2
Wu, C.L.3
|